Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
00003-2328-22 - ipilimumab Soln (OTHER 1279402-2215105) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 15, 2026 , from http://ppman.hank.ai/transparency/procedure/1279402-2215105/by-state?code_type=OTHER
“00003-2328-22 - ipilimumab Soln (OTHER 1279402-2215105) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/1279402-2215105/by-state?code_type=OTHER. Accessed
November 15, 2026 .
“00003-2328-22 - ipilimumab Soln (OTHER 1279402-2215105) by State,” HANK Price Transparency ,
accessed November 15, 2026 ,
http://ppman.hank.ai/transparency/procedure/1279402-2215105/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
1279402-2215105 — 00003-2328-22 - Ipilimumab Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$342,453
National median
$258,250 – $398,535
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 1279402-2215105 (OTHER), with interquartile range
State Median p25 p75
IN $342,453 $258,250 $398,535